Next Article in Journal
In Vitro Effects of Mitochondria-Targeted Antioxidants in a Small-Cell Carcinoma of the Ovary of Hypercalcemic Type and in Type 1 and Type 2 Endometrial Cancer
Next Article in Special Issue
Prevalence of Hearing Impairment by Age: 2nd to 10th Decades of Life
Previous Article in Journal
Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders
Previous Article in Special Issue
There Is More Than Meets the Eye: Identification of Dual Molecular Diagnosis in Patients Affected by Hearing Loss
 
 
Article
Peer-Review Record

Clinical Heterogeneity Associated with MYO7A Variants Relies on Affected Domains

Biomedicines 2022, 10(4), 798; https://doi.org/10.3390/biomedicines10040798
by Sun Young Joo 1,†, Gina Na 2,3,†, Jung Ah Kim 1,†, Jee Eun Yoo 3, Da Hye Kim 3, Se Jin Kim 1, Seung Hyun Jang 1, Seyoung Yu 1, Hye-Youn Kim 1, Jae Young Choi 3, Heon Yung Gee 1,* and Jinsei Jung 3,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomedicines 2022, 10(4), 798; https://doi.org/10.3390/biomedicines10040798
Submission received: 8 March 2022 / Revised: 26 March 2022 / Accepted: 28 March 2022 / Published: 29 March 2022
(This article belongs to the Special Issue Genetic Research on Hearing Loss)

Round 1

Reviewer 1 Report

The paper "Clinical heterogeneity associated with MYO7A variants relies on
affected domains"  provides new information on the MYO7A gene. Some new mutations are reported as well as audiological data that add useful help to the genotype-phenotype correlation. The paper is very clear

Author Response

We thank the reviewer for constructive comments

Reviewer 2 Report

In this manuscript, the authors performed whole exome sequencing on 300 Korean families. They report for the first time the incidence rates of DFNA11 for a Korean population. They also report two novel and likely pathogenic DFNA11 variants in the MyTHR4 domain of MYO7A. Overall, the manuscript is written well. The methodology and results are presented clearly. The conclusions are supported by the data presented. I have no major critiques.

Author Response

We thank the reviewer for constructive comments.

Back to TopTop